Accordingly, targeting the SQORROS axis is seen as a promising therapeutic strategy for UC, though the precise molecular pathways involved and the efficacy in humans remain to be further verified
[] Additionally, GLP-2 and GIP both minimize bone resorption in humans, [] but the molecular mechanism involved is poorly understood
[DOI] [PubMed] [Google Scholar] 66.Huang W, de la Iglesia-Garca D, Baston-Rey I, Calvio-Suarez C, Lario-Noia J, Iglesias-Garcia J, Shi N, Zhang X, Cai W, Deng L, Moore D, Singh VK, Xia Q, Windsor JA, Domnguez-Muoz JE, Sutton R
This heterogeneity precluded us from further interpreting the results and their generalizability
Diabetes 1999- 48:2270-2276